There is a familiar sequence in businesses that are missing revenue targets. Sales says the leads are poor. Marketing points to the volume it delivered and the cost per enquiry it improved. The board asks for more of the thing that is easiest to buy, which is usually leads. A demand generation programme gets approved, activity goes up, and two quarters later the shortfall is roughly the same size as before.
Everyone in that sequence is behaving rationally. Lead volume is often the only variable a leadership team can see clearly. Pipeline health is not on the dashboard, because most pipeline reporting describes what the pipeline contains rather than how it behaves.
That distinction is the whole problem. Value and coverage tell you what people have entered into a system. Health tells you whether those entries mean anything.
The quickest way to tell whether you have a lead volume problem
Three questions, answered from your own data rather than from memory.
What percentage of the opportunities created last quarter reached the next stage, and the one after that? How old is the average open deal, and how does that compare with the deals you actually won? Why did you lose the last ten deals you expected to win, in terms specific enough that someone could act on it?
If those answers are not readily available, the constraint is unlikely to be lead volume. Adding demand to a pipeline nobody can read does not change the rate at which deals close. It increases the amount of work required to produce the same revenue, and it buries the evidence you would need to work out why.
This is not an argument against generating demand. It is an argument about sequence. Lead generation is an amplifier. It multiplies whatever your commercial process already does, including the parts that lose money.
What a healthy pipeline actually looks like
A healthy pipeline is not a large one. It is one where four things are true.
Every open deal sits at its stage for a reason you could show someone. Stages should be defined by evidence from the buyer, not by activity from the seller. "Proposal sent" is something you did. "Buyer has confirmed budget, timing and who signs" is something you learned. Only the second kind of definition tells you anything about the likelihood of closing.
Deals move at a rate you can describe. Health is visible in velocity and ageing, not in the total. Two pipelines of identical value behave completely differently if one has an average open deal age of five weeks and the other has deals that have been open since last summer. The second is not a pipeline. It is a list.
Ageing is worth treating as a warning signal rather than an administrative metric. Ebsta and Pavilion's 2024 analysis of 4.2 million opportunities found that opportunities spending 50 per cent longer than average in qualification were 120 per cent more likely to slip, and that more than seven days of inactivity was associated with a 65 per cent reduction in win rate.
Conversion between stages is stable enough to plan against. Stability matters more than the absolute number. A business that converts 18 per cent of qualified opportunities every quarter can make investment decisions. A business that converts 30 per cent and then 9 per cent cannot, and probably has a definitional or mix problem worth investigating before it has a volume problem.
That is also why a single universal "good" conversion rate is not useful. The comparison that matters is your own rate by stage, segment and source over time, with an external benchmark as a sense-check rather than a target.
Losses are recorded in a way that changes a decision. If most of your loss reasons say "price", you almost certainly do not have enough information yet to conclude that you have a pricing problem. You may simply have a reporting field that nobody has been given a reason to complete honestly.
Coverage ratios depend on all four of those things being true, so treat them with care. A three-times coverage rule is a planning heuristic, not a law of nature, and it is only as good as the stage definitions and data quality underneath it.
Symptoms that get misread as a shortage of leads
What leadership sees in the dashboard often triggers a familiar blame game, but the underlying issue is usually a gap in shared definitions, process design or measurement scope.
Sales says lead quality is poor. Leadership hears a targeting or channel problem. More often there is no agreed, recorded definition of a good-fit account, so "quality" remains an opinion that cannot be queried or improved.
The forecast slips by a quarter, repeatedly. The surface explanation is optimistic sellers. More often the stages are defined by seller activity rather than buyer progress, so deals advance in the system while the buyer has not moved.
Plenty of open opportunities, few closings. The instinctive diagnosis is pricing pressure. What is actually happening is that deals are stalling rather than dying, and nothing in the process forces a decision either way.
Conversion rates look fine but revenue misses. The usual conclusion is not enough at the top of the funnel. The hidden dynamic is deal mix: more small deals closing faster, fewer large deals progressing.
Marketing, sales and web numbers disagree. The first assumption is an analytics configuration error. The deeper issue is that tracking was built to report on channels and never extended to the commercial stages leadership decisions depend on.
In each case the visible symptom points at the top of the process, while the likely cause sits in the definitions, the handover or the record.
Fit is particularly worth quantifying. Ebsta found that opportunities matching a company's ideal customer profile recorded 3.1 times higher win rates, yet only 18 per cent of pipeline matched the profile. That is an unusually clear example of why "more pipeline" and "more useful pipeline" are not the same instruction.
Why pipelines stop being readable
Most pipelines are not badly designed. They are designed once, for a business that has since changed, and then never revisited.
Stages get written from the seller's point of view because that is who fills them in. Fields get added for reporting requests and never retired. Lifecycle definitions get agreed verbally between a marketing lead and a sales lead who have both since left. Meanwhile the business adds a market, a product line or a partner channel, and the model quietly stops describing how revenue is actually won.
Systems make it worse when they fragment. When marketing, sales and customer teams work in separate tools, nobody has a reliable single version of the customer journey, and manual reconciliation becomes a permanent tax on the people you least want doing admin. This is CRM and revenue operations work rather than a reporting inconvenience.
Our work with Kefron, a document storage and information management business, shows what changes when it is addressed. Teams operating in disconnected systems with spreadsheets and no reliable single source of truth moved to a unified platform with rebuilt pipelines, lifecycle stages and role-specific dashboards. The value was not the software. It was that bottlenecks became locatable.
Which is worth saying plainly: you may not need a new CRM. Replacing the system rarely fixes definitions, ownership or discipline, and a migration performed on top of unresolved definitions simply reproduces them in a more expensive tool. Ask first whether your current system is genuinely incapable of representing how you sell, or whether nobody has ever configured it to try.
A diagnosis you can complete in a fortnight
None of this requires a new platform, a research programme or an agency. It requires four quarters of closed deals and someone with the authority to ask awkward questions.
Start with closed deals, not open ones. Open pipeline reflects what people currently believe. Closed deals, won and lost, are the only record of what actually happened.
Rebuild the stage conversion table by hand. Opportunities created, then the percentage reaching each subsequent stage, split by source and by segment. Do it in a spreadsheet before you build a dashboard. You are looking for the stage where the drop is steepest and least explained.
Measure age and movement, not just count. How long do won deals take? How many open deals have exceeded that by 50 per cent or more, and what is anyone doing about them? Introduce a stall threshold and a rule for what happens when a deal crosses it.
Score won and lost deals against fit retrospectively. Take the profile you claim to target, apply it to the last two quarters, and compare hit rates. If good-fit accounts convert materially better, you have quantified the cost of an undefined ideal customer profile, and you have the basis for a scoring model rather than an argument.
Read the last twenty loss reasons as prose. Not the dropdown values, the notes. Then ask the sellers involved. The gap between the field and the conversation tells you how much your loss data is worth.
Reconcile three numbers for one month. Enquiries in your web analytics, contacts created in your CRM, opportunities accepted by sales. Where they disagree, find out why once, and document it. Numbers nobody trusts get replaced in meetings by anecdotes, and anecdotes are always about the most recent deal rather than the most representative one.
If that reconciliation is the part you cannot complete, the problem is marketing analytics and reporting before it is anything else.
What to fix before you buy more demand
Sequence matters more than scope.
Definitions come first, because everything else measures against them: what a good-fit account is, what evidence moves a deal to each stage, what a stalled deal is and who owns it. Then the handover, including what sales receives with a lead and what marketing gets back. Then reporting built around the decisions you actually make, which is usually where to put the next pound and which deals need help this week, rather than reporting built around what the tool happens to display.
When more leads genuinely is the answer
Sometimes it is, and treating every shortfall as an operational problem is its own form of avoidance. Buying more demand is a reasonable decision when four conditions hold at once.
Conversion between stages is understood and reasonably stable. Fit is defined and enforced, so additional volume arrives with a filter rather than replacing one. Sales has genuine capacity, meaning current opportunities are receiving proper attention rather than being triaged. And your losses point outwards rather than inwards: you are losing to competitors you were never shortlisted against, or to buyers who had never heard of you, rather than to your own follow-up and process.
That last condition is the useful one. If you are losing because you were unknown, that is a demand and visibility problem and more investment is justified. If you are losing because you were unconvincing, slow or inconsistent, additional leads will simply give you more opportunities to lose in the same way.
The question worth asking at your next pipeline review
Most pipeline reviews ask how much is in the pipeline. A more useful question is what would have to be true for each significant deal to close, and whether anyone has evidence that it is.
A pipeline is a set of claims about the future. Its health is not the size of those claims but the speed at which the wrong ones surface. Businesses that grow predictably are rarely the ones with the most in the pipeline. They are the ones that find out fastest when a deal is not real, and spend the recovered time on the deals that are.
If the pattern in your business is plenty of interest but unpredictable revenue, start with the pipeline you already have rather than the one you were about to buy. More on how we help you build a stronger pipeline, or, if the issue sits specifically in what happens after a lead arrives, turn interest into sales.
Find out what your pipeline is actually telling you.
We will run the fortnight diagnosis above against your own closed deals and show you where the drop-off sits. If the answer is that you do need more demand, we will tell you that too.
